| Literature DB >> 24813520 |
Emily M Contreras1, Sandeep K Gupta2.
Abstract
Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids. New studies on alternative delivery systems and different corticosteroids (eg, ciclesonide) are encouraging. As knowledge of corticosteroids in eosinophilic esophagitis expands, newer questions continue to arise concerning dose, delivery, and choice of corticosteroids; long-term adverse effects; and maintenance therapies.Entities:
Keywords: Budesonide; Children; Ciclesonide; Eosinophilic esophagitis; Fluticasone; Steroids; Topical steroids
Mesh:
Substances:
Year: 2014 PMID: 24813520 PMCID: PMC6662919 DOI: 10.1016/j.gtc.2014.02.008
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806